Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7293 USD | +4.08% |
|
-2.76% | -30.54% |
Jun. 26 | Transcript : Quince Therapeutics, Inc. - Special Call | |
Jun. 25 | Quince Therapeutics Doses First Patient in Phase 3 Trial of EryDex to Treat Ataxia-Telangiectasia | MT |